There are some constraints without FDA for marketing in the US....

There are some constraints without FDA for marketing in the US. Apparently sales are increasing and once FDA is approved the company will be allowed to market more aggressively and we then may see some decent deals go through.

I cant put figures on it, but the window is open right now for this company to take advantage of and the next 6 months should see a steady rise on back of positive news.

My news is filing this week... and judging from previous company emails we may get mexico contract released before filing announcement if they announce it at all.

Investor update i have marked for October 24th and this should summarise things and make things clearer for us.

Either way whatever sums you come up the market cap is well below potential.

I hold many.